Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Dahlöf, Björn, Devereux, Richard B, Kjeldsen, Sverre E, Julius, Stevo, Beevers, Gareth, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristiansson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Wedel, Hans, Coats, A and , LIFE study group (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet, 359 (9311). pp. 995-1003.

Full text not available from this repository.
Item Type: Article
Faculty \ School: ?? FMH ??
Related URLs:
Depositing User: Rhiannon Harvey
Date Deposited: 01 Jul 2011 12:08
Last Modified: 28 Aug 2018 16:31
URI: https://ueaeprints.uea.ac.uk/id/eprint/33179
DOI: 10.1016/S0140-6736(02)08089-3

Actions (login required)

View Item